Clinical Trial Update: Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a rifaximin and misoprostol combination therapy targeting healing of small bowel ulcers in aspirin users, currently in Phase 2/Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Bowel Disease

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Rifaximin (rifaximin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Small Bowel Disease, Rifaximin | Phase 2, Phase 3 | Status: UNKNOWN